Orchid Pharma | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Development
Email & Communication
Keywords & Focus Areas
Orchid Pharma
Overview
Orchid Pharma Limited is an Indian pharmaceutical company founded in 1992 and based in Chennai. Established by K. Raghavendra Rao, the company specializes in the research-driven manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). The organization is recognized as one of the top Fortune 500 Indian companies by market capitalization as of 2024 and exports to over 30 countries, maintaining compliance with international standards such as the US FDA and UK MHRA.
As a leading manufacturer of APIs, particularly in the anti-infective segment, the company has achieved significant breakthroughs in new drug discovery, including the global approval of Enmetazobactam, a New Chemical Entity. Its diverse product portfolio includes over 100 marketed products across multiple therapeutic areas. Serving a range of international pharmaceutical companies and domestic healthcare providers, Orchid Pharma is committed to quality and innovation within the pharmaceutical industry.
Basic Information
| Industry | Pharmaceuticals |
|---|---|
| Founded | 1992 |
| Revenue | 128.5M |
| Headquarters | 'Orchid Towers', #313, Valluvar Kottam High Road, Nungambakkam, Chennai, Tamil Nadu 600034, India |
| Languages | English |
| Alexa Ranking |
Contact Details
- Phone: +91 44 2821 1000
- Website: orchidpharma.com
- LinkedIn: linkedin.com/company/orchid-pharma
Key Focus Areas & Initiatives
- Marketing & collaborations
- Pharmaceutical manufacturing
- Market leadership
- Services
- Export-oriented manufacturing
- Foreign pharma collaborations
- Pharma R&D partnerships
- Formulation manufacturing
- Biopharmaceuticals
- Research collaborations
- International partnerships
- Healthcare
- API manufacturing
- Pharma research collaborations with academia
- Research and development
- Pharma exports
- Enmetazobactam
- Market expansion
- Injectable drugs
- Pharma quality control
- Pharmaceutical research
- Injectable cephalosporins
- Pharma technology transfer
- Regulatory approval in US and Europe
- Innovation
- Export-oriented
- Biopharmaceutical innovation
- Pharma product pipeline
- Pharma partnerships
- International markets
- Sustainability
- Supply chain management
- Product development
- Pharma manufacturing excellence
- Advanced formulation techniques
- Herbal medicine research
- Pharma R&D foreign investments
- Global markets
- Foreign investments
- Pharma export compliance
- Investment
- Drug manufacturing
- Innovative drug discovery
- Manufacturing
- Pharma R&D
- Antibiotic formulations
- Clinical research collaborations
- B2B
- Pharma export markets
- Antibiotic APIs
- Sterile injectable manufacturing
- Drug pipeline
- Regulatory approvals
- Formulations
- Innovative antibiotic research
- Research
- Export-oriented pharma units
- Biotech in pharma manufacturing
- Pharma innovation
- New chemical entity
- NCE drug development
- Specialty antibiotics manufacturing
- Pharma manufacturing process
- Biotech collaborations
- Drug discovery in India
- Biotech research in pharma
- India pharma
- Cephalosporins
- Regulatory compliance
- Pharma supply chain management
- Sterile products
- Pharma industry standards
- Global pharmaceutical supply
- Pharmaceutical and medicine manufacturing
- API production
- Antibiotics
- Compliance
- Portfolio management
- Pharma R&D investment
- Biotechnology
- Pain management drugs
- Pharma export regulations
- Clinical trial management
- Drug discovery
- Quality assurance
- Pharma quality assurance standards
- Sterile manufacturing
- Formulation development
- Pharma regulatory strategy
- R&D collaborations
- Clinical research
- Global pharma supply chain
- New drug discovery in India
- Pharma technology
- API
- Cephalosporin APIs
- Pharma supply chain
- Bulk drugs
- Pharma quality standards
- Pharmaceuticals
- Clinical trials
- Global supply chain
- Drug development
- Active pharmaceutical ingredients
- Multi-therapeutic
- Anti-infectives
- Anti-inflammatory
- CNS
- Central nervous system
- CVD
- Cardiovascular
- Nutraceuticals
- Oral products
- Value chain
- Discovery to delivery
- Integrated model
- Global generics
- Industry experience
- Corporate social responsibility
- Sustainable procurement
- Stakeholder value
- Drug delivery
- Pharmaceutical solutions
- Export-oriented unit
- Team empowerment
- Niche products
- Financial management
- Leadership
- Operational excellence
- Market presence
- Business partnerships
- Strategic growth
- Market access
- Pharma alliances
- Collaborative innovation
- R&D
- Brand positioning
- Cost efficiency
- Distribution
- Transportation & logistics
- Medical
- Health care
- Health, wellness & fitness
- Hospital & health care
- Research & development
- Environmental services
- Renewables & environment
- Logistics & supply chain
- Mechanical or industrial engineering
Technologies Used
- Bootstrap Framework
- Google Font API
- Mobile Friendly
- Outlook